Results
1 -
8 of
8Treatment with bindarit, an inhibitor of MCP-1 synthesis, protects mice against trinitrobenzene sulfonic acid-induced colitis, Inflammation Research Bindarit Attenuates Pain and Cancer-Related Inflammation by Influencing Myeloid Cells in a Model of Bone Cancer, Archivum Immunologiae et Therapiae Experimentalis Amelioration of rat adjuvant arthritis by therapeutic treatment with bindarit, an inhibitor of MCP-1 and TNF-?? production, Inflammation Research Targeting monocyte chemotactic protein-1 synthesis with bindarit induces tumor regression in prostate and breast cancer animal models, Clinical & Experimental Metastasis Therapies on the Horizon for Diabetic Kidney Disease, Current Diabetes Reports The CCL2 synthesis inhibitor bindarit targets cells of the neurovascular unit, and suppresses experimental autoimmune encephalomyelitis, Journal of Neuroinflammation In brief u2026, Inpharma Weekly